NCT07464925 2026-03-11
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Tetragon Biosciences Ltd
Phase 1 Not yet recruiting
Clinical Trials
18 trialsNCT07455045 2026-03-06
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07346144 2026-03-04
ADePT
Trogenix ltd
Phase 1/2 Not yet recruiting
NCT07431216 2026-02-24
A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression
Lantern Pharma Inc.
Phase 1/2 Not yet recruiting
NCT07356973 2026-01-26
OPTICAL
CRISM Therapeutics LTD
Phase 2 Not yet recruiting
NCT07365280 2026-01-26
Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma
ZSky Biotech Inc
Phase 2 Not yet recruiting
NCT07366892 2026-01-26
IMED-GLOW400
Leica Microsystems (Schweiz) AG
Not yet recruiting
NCT07349693 2026-01-20
Cerebraca-02/3
Everfront Biotech Co., Ltd.
Phase 2/3 Not yet recruiting
NCT07274397 2025-12-10
EARLYBRAINPET
Beta Emitting Accurate Monitored Systems
Phase NA Not yet recruiting
NCT04373785 2025-10-21
NG101m Adjuvant Therapy in Glioblastoma Patients
NeuGATE Theranostics
Phase 1/2 Not yet recruiting
NCT07185880 2025-09-22
STAR-GBM
Myosin Therapeutics Inc.
Phase 1 Not yet recruiting
NCT07138001 2025-08-22
Phase 2 Clinical Trial of KH617
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Phase 2 Not yet recruiting
NCT04933422 2024-08-21
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
Crimson Biopharm Inc.
Phase 1 Not yet recruiting
NCT06524063 2024-07-29
Targeted Survivin DC Cell Injection for the Treatment of GBM
Beijing Tricision Biotherapeutics Inc
Phase 1 Not yet recruiting
NCT06329570 2024-03-26
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
NaviFUS Corporation
Phase 1/2 Not yet recruiting
NCT05958485 2023-07-24
A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
Power Life Sciences Inc.
Not yet recruiting
NCT05728125 2023-06-12
Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
Power Life Sciences Inc.
Not yet recruiting
NCT05095441 2022-10-12
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
ImmVira Pharma Co. Ltd
Phase 1 Not yet recruiting